Disease/Infection News

RSS

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

Researchers have conducted a prospective, longitudinal cohort study to analyze COVID-19 immunity in patients with cancer.

9 Feb 2022

AI based home monitoring during COVID-19 pandemic

Researchers conducted an open, prospective pilot feasibility analysis through artificial intelligence (AI)-based platform to provide clinical decision support on COVID-19 outcomes.

9 Feb 2022

Surveillance for potentially zoonotic viruses in rodent and bat populations in an agricultural settlement in Ghana

In a new study, researchers investigated viruses in bats and rodents - key reservoir hosts for zoonotic viral pathogens, in a small agricultural community in Ghana.

9 Feb 2022

Causality of associations between maternal BMI and child adiposity

Researchers modified the MR study methodologies to ensure a bias-proof evaluation of the causal effect of maternal BMI on offspring adiposity.

9 Feb 2022

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

Scientists have recently studied the duration of protection provided by mRNA-based COVID-19 vaccines against symptomatic omicron infection, and associated severity and mortality.

9 Feb 2022

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Researchers looked at the efficiency of COVID-19 vaccines in preventing infection, hospitalization, and death in the general population of Sweden over the first nine months following vaccination.

9 Feb 2022

Study finds strong evidence of extensive SARS-CoV-2 infection of white-tailed deer

The scientists tested samples collected from free-living and confined deer in Iowa to see if infection and subsequent transmission of SARS-CoV-2 in deer happens in nature.

9 Feb 2022

Danish study of long COVID in teens

As an aftermath of the extended lockdowns and social distancing restrictions, Coronavirus disease 2019 (COVID-19) has impacted the quality of life of children and adolescents worldwide, not only physically due to the infection, but also mentally. A high level of anxiety and depression has been reported among pediatric patients and adolescents, many of whom were deprived of social interaction with peers during the pandemic.

9 Feb 2022

Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic

The origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has long been debated among scientists. However, prior research found early genetic material of a unique SARS-CoV-2 variant from the soil on King George Island, Antarctica between 24 December 2018 and 13th January 2019.

9 Feb 2022

Reviewing breath biomarkers for inflammatory respiratory diseases

The prevalence of inflammatory airway diseases such as lung cancer, chronic obstructive pulmonary disease (COPD) and asthma is on the rise internationally, placing strain on health systems around the world. Lung cancer is the leading cause of death of all cancers.

From Owlstone Medical Ltd 8 Feb 2022

Study highlights benefit of mRNA boosters for SARS-CoV-2 following different initial vaccine types

A study by researchers from the United Kingdom finds no difference in the protection offered by mRNA vaccine boosters against the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) when comparing those that have received BioNTech/Pfizer vaccine as a primary course to those that have received Oxford/AstraZeneca.

8 Feb 2022

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury and the risk of blood clots in severe COVID-19 and other disorders that cause immune-mediated damage to the lungs, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.

8 Feb 2022

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Mycology and immunology researchers from The University of Texas at San Antonio have been selected to receive a five-year, $6.8 million grant from the National Institutes of Health to establish a San Antonio-based Coccidioidomycosis Collaborative Research Center (SA-CCRC) focused on developing therapeutics and vaccines against coccidioidomycosis.

8 Feb 2022

Disease/Infection News

Study explores adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants post-immunization in cancer patients

AI based home monitoring during COVID-19 pandemic

Surveillance for potentially zoonotic viruses in rodent and bat populations in an agricultural settlement in Ghana

Causality of associations between maternal BMI and child adiposity

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Study finds strong evidence of extensive SARS-CoV-2 infection of white-tailed deer

Danish study of long COVID in teens

Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic

Reviewing breath biomarkers for inflammatory respiratory diseases

Study highlights benefit of mRNA boosters for SARS-CoV-2 following different initial vaccine types

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

The B and T cell responses to SARS-CoV-2

Swedish study shows fully vaccinated are protected against severe COVID-19

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

Impact of SARS-CoV-2 Omicron and Delta variants on serious hospital events

Exploring the high incidence of croup in children during the SARS-CoV-2 Omicron wave

Comparison of school protocols under the high incidence conditions due to the Omicron variant

The impact of SARS-CoV-2 variants on clinical trajectory and outcome

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News